Mentor ObTape Bladder Sling Pulled From the Market After Causing Crippling Complications
Posted: Tuesday, February 17, 2009
by Kelly Knapp
Bernstein Liebhard LLP
In the past three years, the Food and Drug Administration (FDA) has received over a thousand reports of complications caused by the use of the Mentor ObTape Bladder Sling. Introduced in 2003, the manufacturer of the Mentor ObTape Bladder sling stopped marketing it just three years later in 2006.
Obtape bladder slings are used primarily to treat urinary incontinence. Patients who suffer from this condition cannot control when they urinate, and experience problematic leakage. Approximately 12 million adults in the United States suffer from this condition, most commonly women over 50 years old, or women who have just given birth.
This condition is easily treatable, and has been treated with bladder slings for about 100 years. Bladder slings have been the most common and most effective treatment for this affliction. The bladder slings function as a hammock to support the bladder and reinforce the muscles that control the flow of urine from the body. This requires minimally invasive surgery, and can be done on an outpatient basis.
However, almost as soon as the Mentor ObTape bladder sling was introduced, patients began to complain of serious complications. Most bladder slings are made with a woven or mesh design to allow surrounding tissue to receive nutrients and oxygen. The Mentor Bladder Sling did not have this design, which not only impaired healing, but actually contributed to the erosion of the tissue of the vaginal wall, as well as erosion of the urethra. This breakdown of tissue leads to chronic vaginal discharge and painful vaginal extrusions. After such widespread complications, Mentor was forced to pull the ObTape Bladder Sling from the market.
The Consumer Injury Lawyers website is a consumer advocacy website that provides information about ObTape Bladder Sling lawsuits The site also provides information about lawsuits involving transvaginal placement of potentially defective surgical mesh used to treat Pelvic Prolapse (POP) and Stress Urinary Incontinence (SUI), including Bard Avaulta Mesh lawsuits .
This Article has been viewed 2,062 times. (Not updated in real-time.)
Top-level comments on this article: (1 total)hi kelly,i know of this problem, and it can be very debilitating.i hope researchers find something to help women who have this problem.thanks for shaing and i hope you continue writing,welcome to searchwarp,best regards,sue thom
We want your comments! If you can read this, you don't have javascript enabled, so you can't use this comment system. Please enable javascript.
